Abstract
It is well documented that certain substituted benzamides, such as cisapride, and benzimidazolones, such as BIMU 8, enhance gastric emptying in rats. As these compounds possess 5-HT3 antagonistic and 5-HT4 agonistic properties, the precise mechanisms (5-HT3 or 5-HT4) underlying their gastroprokinesic effects is still unclear. In the present study, we used SC 49518 (a benzamide and selective 5-HT4 receptor agonist) and two selective 5-HT4 receptor antagonists (RS 23597-190 and SB 204070) to elucidate the role of 5-HT4 receptors in gastroprokinesis. SC 49518 (1–316 μg/kg; ip) produced significant and dose-dependent stimulation of gastric emptying in rats (ED50 = 2.3 μg/kg; ip). SC 49518 also produced dose-dependent inhibition of bradycardia induced by 2-methyl 5-HT (von Bezold-Jarisch reflex) but with a 156 fold lower potency (ID50 = 0.36 mg/kg; ip). The gastroprokinetic effects of SC 49518 (3–316 μg/kg; ip) were significantly antagonized by the selective 5-HT4 receptor antagonist RS 23597-190 (0.1 mg/kg/min; iv). SB 204070 (0.003-1 mg/kg; ip), another selective 5-HT4 receptor antagonist, produced dose-dependent inhibition of the gastroprokinesic effects of SC 49518 (10 μg/kg; ip), the inhibition attaining statistical significance at the dose of 0.1 mg/kg; ip. RS 23597-190 had no effects on gastric emptying per se whereas SB 204070 significantly increased gastric emptying by itself at 1 mg/kg; ip but not at 0.1 mg/kg; ip. These findings show, for the first time, that SC 49518, a selective 5-HT4 receptor agonist, produces potent stimulation of gastric emptying in rats via a mechanism involving activation of 5-HT4 receptors. It is suggested that a similar mechanism may account for the gastroprokinetic effects of other non-selective benzamides and benzimidazolones.
Similar content being viewed by others
References
Banner SE, Smith MI, Bywater D, Sanger GJ (1993) 5-HT4 receptor antagonism by SB 204070 inhibits 5-hydroxytryptophan-evoked defecation in mice. Br J Pharmacol 110:17P
Baxter GS, Craig DA, Clarke DE (1991) 5-hydroxytryptamine4 receptors mediate relaxation of the rat oesophagus tunica muscularis mucosae. Naunyn-Schmiedeberg's Arch Pharmacol 212:225–229
Bingham S, King BF, Rushant B, Smith MI, Sanger GJ (1993) The 5-HT4 receptor antagonist SB 204070 inhibits the contractile response to 5-HT in the dog Heidenhain pouch. Br J Pharmacol 110:16P
Cohen ML, Bloomquist W, Gidda JS, Lacefield W (1990) LY 277359 maleate: A potent and selective 5-HT3 receptor antagonist without gastroprokinetic activity. J Pharmacol Exp Ther 254: 350–355
Costall B, Gunning SJ, Naylor RJ, Simpson KH (1983) A central site of action for benzamide facilitation of gastric emptying. Eur J Pharmacol 91:197–205
Costall B, Gunning SJ, Naylor RJ (1985) An analysis of the hypothalmic sites at which substituted benzamide drugs act to facilitate gastric emptying in the guinea pig. Neuropharmacology 24:869–875
Droppleman DA, Gregory RL, Alphin RS (1980) A simplified method for assessing drug effects on gastric emptying in rats. J. Pharmacol Methods 4:227–230
Dumuis A, Sebben M, Bockaert J (1989) The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT (5-HT4) receptor positively coupled to adenylate cyclase in neurons. Naunyn Schmiedeberg's Arch Pharmacol 340:403–410
Eglen RM, Bley K, Bonhaus DW, Clark RD, Hegde SS, Johnson LG, Leung E, Wong EHF (1993) RS 23597–190: a potent and selective 5-HT4 receptor antagonist. Br J Pharmacol 110: 119–126
Flynn DL, Zabrowski DL, Becker DP, Nosal R, Villamid CI, Gullikson GW, Moummi C, Yang D-C (1992) SC 53116: the first selective agonist at the newly identified 5-HT4 receptor subtype. J Med Chem 35:1486–1489
Ford APDW, Baxter GS, Eglen RM, Clarke DE (1992) 5-hydroxytryptamine (5-HT) stimulates cyclic AMP formation in the tunica muscularis mucosae (TMM) of the rat oesophagus via 5-HT4 receptors. Eur J Pharmacol 211:117–120
Ford APDW, Clarke DE (1993) The 5-HT4 receptor. Med Res Rev 13:633–662
Gale JD, Reeves JJ, Bunce KT (1994) Antagonism of the gastroprokinetic effect of metoclopramide by GR 125487, a potent and selective 5-HT4 receptor antagonist. J Gastrointestinal Motility 5:192
Gullikson GW, Loeffler RE, Virina MA (1991a) Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor stimulating actions of prokinetic drugs in dogs. J Pharmacol Exp Ther 258:103–110
Gullikson GW, Yang D, Wang S-X, Moummi C, Goldstein B, Flynn D, Zabrowski D, Nosal R, Gaginella TS (1991b) Interaction of SC 49518 with 5-HT4 receptors of the gastrointestinal tract is the basis for its prokinetic activity. Gastroenterology 100:A446
Gullikson GW, Loeffler RF, Yang DC, Virina MA, Goldstin B, Flynn DL, Becker DP, Nosal RA (1992) Stereoselective 5-HT4 receptor agonism and gastrointestinal prokinetic activity is demonstrated by SC 53116, the active isomer of SC 49518. Gastroenterology 102:A455
Gullikson GW, Virina MA, Loefller RF, Yang D-C, Goldstin B, Wang S-X, Moummi C, Flynn DL, Zabrowski DL (1993) SC 49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism. J Pharmacol Exp Ther 264: 240–248
Hegde SS, Ku P, Lai K, Eglen RM (1994a) 5-HT4 receptor mediated contraction of colon in the anesthetized guinea-pig. Br J Pharmacol 112:559P
Hegde SS, Moy TM, Perry MR, Loeb M, Eglen RM (1994b) Evidence for the involvement of 5-HT4 receptors in 5-hydroxytryptophan-induced diarrhea in mice. J Pharmacol Exp Ther 271:741–747
Ku P, Wong AG, Perry MR, Eglen RM, Hegde SS (1993) Evidence for the involvement of 5-HT4 receptors in the gastroprokinetic effects of SC 53116 in rats. The Pharmacologist 35:330
Leung E, Michelson S, Villarubia C, Perkins LA, Eglen RM (1992) Analysis of concentration-response relationships by Seemingly Unrelated non-linear regression (SUNR) technique. J Pharmacol Methods 4:209–216
Linnik MD, Butler BT, Gaddis RR, Ahmed NK (1991) Analysis of serotonergic mechanisms underlying benzamide-induced gastroprokinesis. J Pharmacol Exp Ther 259:501–507
Rizzi CA, Sagrada A, Schiavone A, Schiantarelli P, Cesana R, Schiavi GB, Ladinsky H, Donetti A (1994) Gastroprokinetic properties of the benzimidazolone derivative BIMU 1, an agonist at 5-hydroxytryptamine4 and antagonist at 5-hydroxytryptamine3 receptors. Naunyn Schmiedeberg's Arch Pharmacol 349:338–345
Sanger GJ (1987) Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924 Br J Pharmacol 91:77–87
Schiavone A, Volonte M, Micheletti R (1990) The gastrointestinal motor effect of benzamide derivatives is unrelated to 5-HT3 receptor blockade. Eur J Pharmacol 187:323–329
Schiantarelli P, Bockaert J, Cesana R, Donetti A, Dumuis A, Giraldo E, Ladinsky H, Monferini E, Rizzi C, Sagrada A, Schiavone A (1990) The prokinetic properties of new benimidazole derivatives are related to 5-HT 4 agonism. Pharmacol Res 22:453
Turconi M, Schiantarelli P, Borsini F, Rizzi CA, Ladinsky H, Donetti A (1991) Azabicycloalkyl benzimidazolones: Interaction with serotenergic 5-HT3 and 5-HT4 receptors and potential therapeutic implications. Drug of the Future 16:1011–1026
Valdovinos MA, Thomforde GM, Camilleri M (1993) Effect of putative carcinoid mediators on gastric and small bowel transit in rats and the role of 5-HT receptors. Aliment Pharmacol Ther 7:61–66
Wardle KA, Sanger GJ (1993) The guinea-pig distol colon — a sensitive preparation for the investigation of 5-HT4 receptor-mediated contractions. Br J Pharmacol 110:1593–1599
Wardle KA, Ellis ES, Baxter GS, Kennett GA, Gaster FD, Sanger GJ (1994) The effects of SB 204070, a highly potent and selective 5-HT4 receptor antagonist, on guinea-pig distal colon. Br J Pharmacol 112:789–794
Wiseman LR, Faulds D (1994) Cisapride: An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 47:116–152
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hegde, S.S., Wong, A.G., Perry, M.R. et al. 5-HT4 receptor mediated stimulation of gastric emptying in rats. Naunyn-Schmiedeberg's Arch Pharmacol 351, 589–595 (1995). https://doi.org/10.1007/BF00170157
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00170157